V
Market Data
$8.01+$1.17 (+17.11%)
VNDA · Last trade
Prev Close
$6.84
Range (30d)
$6.91 – $8.82
Recent Filings
- 8-K239.0 KBVanda Pharmaceuticals Inc.Jan 8, 7:09 AM ET·0001628280-26-001273
- 8-K251.9 KBVanda Pharmaceuticals Inc.Dec 30, 6:45 PM ET·0001628280-25-059155
- 8-K232.2 KBVanda Pharmaceuticals Inc.Dec 4, 4:39 PM ET·0001628280-25-055393
- 8-K233.0 KBVanda Pharmaceuticals Inc.Nov 28, 7:06 AM ET·0001628280-25-054225
- 10-Q6.4 MBVanda Pharmaceuticals Inc.Oct 30, 7:23 AM ET·0001628280-25-047317
- 8-K363.3 KBVanda Pharmaceuticals Inc.Oct 29, 4:08 PM ET·0001628280-25-047112
- 8-K237.1 KBVanda Pharmaceuticals Inc.Oct 1, 5:10 PM ET·0001628280-25-043489
- 10-Q6.4 MBVanda Pharmaceuticals Inc.Jul 31, 8:57 AM ET·0001628280-25-036861
- 8-K353.7 KBVanda Pharmaceuticals Inc.Jul 31, 7:34 AM ET·0001628280-25-036843
- 8-K166.5 KBVanda Pharmaceuticals Inc.Jun 5, 4:32 PM ET·0001628280-25-029678
Insiders
10- Baroldi PaoloSVP & Chief Medical Officer
- BATE KENNETHDirector
- Birznieks GuntherSVP, Business Development
- BLAIR JAMES C10% Owner
- CARE CAPITAL II LLC10% Owner
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chrousos PhaedraDirector
- Clark William DSr. VP, Chief Business Officer
- COLA MICHAEL FDirector
- DEERFIELD MANAGEMENT COMPANY, L.P.10% Owner, Possible Member of 10% Group
Tickers
Addresses
business
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037
mailing
2200 PENNSYLVANIA AVE NW SUITE 300E
WASHINGTON, DC, 20037